Effect of Semiconductor Embedded Therapeutic Gloves for Hand Osteoarthritis
Launched by ALTOONA CENTER FOR CLINICAL RESEARCH · Dec 16, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new type of treatment for people with hand osteoarthritis, a condition that causes pain and stiffness in the hands. The study will test special gloves that have embedded technology to see if they can help reduce symptoms associated with this condition. The goal is to find out if wearing these gloves can make daily activities easier and improve the quality of life for those affected by hand osteoarthritis.
To participate in the trial, individuals must be between the ages of 40 and 75 and diagnosed with a specific type of hand osteoarthritis. They should also be willing to follow the study's guidelines and sign consent forms. However, not everyone can join. For example, people with certain neurological conditions, recent surgeries on their hands, or other types of arthritis won't be eligible. If you join the study, you can expect to wear the gloves regularly and attend follow-up appointments to share your experience with the researchers. This trial is currently not recruiting participants, but it aims to find effective ways to help manage hand osteoarthritis symptoms in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients diagnosed with erosive hand OA, non-erosive hand OA, or first carpometacarpal joint OA with a Kellgren- Lawrence grade \>1 as determined by radiographic assessments and the American College of Rheumatology (ACR) classification
- • 2. Patients age 40-75
- • 3. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
- • 4. Patients who are willing and able to sign corresponding research subject consent form.
- Exclusion Criteria:
- • 1. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
- • 2. Patient has had prior surgical treatment of the hands in the last 5 years or injection treatment in the last 6 months
- • 3. Patient has secondary OA including causes such as gout, rheumatoid arthritis, psoriatic arthritis
- • 4. Patient has used topical creams or gels for arthritic pain including nonsteroidal anti-inflammatory drugs, capsaicin, lidocaine, or counterirritants in the last 1 week
- • 5. Patient has a history of carpal tunnel syndrome, cubital tunnel syndrome, or radial tunnel syndrome
- • 6. Patient has a history of peripheral neuropathy
- • 7. Patient has chronic pain conditions unrelated to hand condition
- • 8. Patient has auto-immune or auto-inflammatory diseases
- • 9. Patient has used tobacco within the last 90 days
- • 10. Patient is not within the ages of 40-75
- • 11. Patient has an active infection (local or systemic)
- • 12. Patient is unwilling or unable to sign the corresponding research subject consent form
- • 13. Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.
- • -
- Exclusion Criteria:
- • -
About Altoona Center For Clinical Research
Altoona Center for Clinical Research is a dedicated clinical research organization committed to advancing medical knowledge through innovative clinical trials. With a focus on patient-centered research, the center collaborates with leading pharmaceutical and biotechnology companies to facilitate the development of new therapies and treatments across various therapeutic areas. Equipped with state-of-the-art facilities and a team of experienced professionals, Altoona Center ensures rigorous adherence to regulatory standards and ethical guidelines, fostering an environment that prioritizes participant safety and data integrity. Through its comprehensive approach to clinical research, the center aims to contribute meaningfully to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Duncansville, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported